REPLIGEN CORP's ticker is RGEN and the CUSIP is 759916109. A total of 448 filers reported holding REPLIGEN CORP in Q1 2022. The put-call ratio across all filers is 1.28 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $225,953 | +12.4% | 1,421 | 0.0% | 0.00% | 0.0% |
| Q2 2023 | $201,015 | -16.0% | 1,421 | 0.0% | 0.00% | 0.0% |
| Q1 2023 | $239,240 | +3.9% | 1,421 | +4.5% | 0.00% | 0.0% |
| Q4 2022 | $230,262 | -42.0% | 1,360 | -35.9% | 0.00% | -50.0% |
| Q3 2022 | $397,000 | +15.1% | 2,123 | 0.0% | 0.00% | +100.0% |
| Q2 2022 | $345,000 | -19.4% | 2,123 | -6.8% | 0.00% | -50.0% |
| Q1 2022 | $428,000 | -29.0% | 2,278 | 0.0% | 0.00% | 0.0% |
| Q4 2021 | $603,000 | -4.6% | 2,278 | +4.1% | 0.00% | -33.3% |
| Q3 2021 | $632,000 | +62.5% | 2,188 | +12.4% | 0.00% | +50.0% |
| Q2 2021 | $389,000 | +2.6% | 1,947 | 0.0% | 0.00% | 0.0% |
| Q1 2021 | $379,000 | -1.3% | 1,947 | -2.7% | 0.00% | 0.0% |
| Q4 2020 | $384,000 | +30.2% | 2,002 | 0.0% | 0.00% | 0.0% |
| Q3 2020 | $295,000 | +22.4% | 2,002 | +2.5% | 0.00% | +100.0% |
| Q2 2020 | $241,000 | – | 1,953 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| 12 West Capital Management LP | 1,021,641 | $295,244,000 | 13.47% |
| Ally Bridge Group (NY) LLC | 70,000 | $20,229,000 | 5.95% |
| Miura Global Management | 85,000 | $24,564,000 | 3.81% |
| Conestoga Capital Advisors, LLC | 871,390 | $251,823,000 | 3.48% |
| Ranger Investment Management | 187,723 | $54,250,000 | 2.90% |
| AWM Investment Company, Inc. | 100,000 | $28,899,000 | 2.84% |
| Brown Capital Management | 1,017,477 | $294,041,000 | 2.41% |
| Stephens Investment Management Group LLC | 558,287 | $161,339,000 | 2.19% |
| Yorktown Management & Research Co Inc | 10,050 | $2,904,000 | 2.18% |
| SV Health Investors, LLC | 14,541 | $4,203,000 | 2.06% |